How have MBOT and TELA total returns compared?

Over the past 5 years, MBOT delivered -31.63% and TELA delivered -38.71% annualized total return. Past performance doesn't predict future results.

Microbot Medical Inc. (MBOT) vs TELA Bio, Inc. (TELA)

A side-by-side comparison of Microbot Medical Inc. and TELA Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

MBOT

Microbot Medical Inc.

$49M

$1.07HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

TELA

TELA Bio, Inc.

$49M

$1.09HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — MBOT vs TELA

growth of $100 · dividends reinvested · last 7y

MBOT -78.7% (-19.8%/yr)TELA -91.5% (-29.6%/yr)MBOT compounded faster over this window

MBOT TELA

MBOT vs TELA: by the numbers

•TELA is the larger company ($49M vs $49M market cap).
•Both run net losses; TELA's is the smaller (-51.53% vs -4722.25% net margin).

Metrics side by side

Valuation

Metric	MBOT	TELA
P/S ratio	140.93	0.61
P/B ratio	0.71	N/A

Profitability

Metric	MBOT	TELA
Gross margin	0.00%	67.81%
Operating margin	0.00%	-42.56%
Net margin	-4722.25%	-51.53%
ROE	-23.70%	N/A
ROIC	-26.51%	-80.88%

Growth (annualized)

Metric	MBOT	TELA
Revenue CAGR (5Y)	N/A	26.77%
Total return CAGR (5Y)	-31.63%	-38.71%

Frequently asked

How have MBOT and TELA total returns compared?: Over the past 5 years, MBOT delivered -31.63% and TELA delivered -38.71% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MBOT analysis Full TELA analysis Interactive comparison tool

Dig into the metrics

Microbot Medical ROE TELA Bio ROE Microbot Medical operating margin TELA Bio operating margin Microbot Medical revenue growth TELA Bio revenue growth Microbot Medical free cash flow TELA Bio free cash flow

Microbot Medical & TELA Bio appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.